New oral anticoagulants in thromboembolism prevention in nonvalvular atrial fibrillation

Authors

  • José Manuel Sosa Rosado Médico Cardiólogo, Clínica Internacional, Lima, Perú.

DOI:

https://doi.org/10.15381/anales.v74i2.2391

Keywords:

Atrial fibrillation, warfarin, direct thrombin inhibitors, direct factor Xa inhibitors.

Abstract

Atrial fibrillation is the most frequent cardiac arrhythmia in clinical practice. The value of anticoagulation with vitamin K antagonists like warfarin in the prevention of embolic phenomena is widely demonstrated but managing is difficult because of its known interactions with other drugs and even food. Looking for the ideal anticoagulant in the last years new antithrombotic agents have appeared and others are in advanced phases of investigation. In the current review results of new anticoagulant agents development and expectations, opportunities and challenges are described in regards to direct thrombin and Xa factor inhibitors.

Downloads

Published

2013-06-10

Issue

Vol. 74 No. 2 (2013)

Section

Artículos de Revisión

License

Copyright (c) 2013 José Manuel Sosa Rosado

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Those authors who have publications with this magazine accept the following terms:

  1. Authors will retain their copyrights and guarantee the journal the right of first publication of their work, which will be simultaneously subject to Creative Commons Attribution License that allows third parties to share the work as long as its author and its first publication this magazine are indicated.
  2. Authors may adopt other non-exclusive licensing agreements for the distribution of the version of the published work (eg, deposit it in an institutional electronic file or publish it in a monographic volume) provided that the initial publication in this magazine is indicated.
  3. Authors are allowed and recommended to disseminate their work over the Internet (eg: in institutional telematic archives or on their website) before and during the submission process, which It can produce interesting exchanges and increase quotes from the published work. (See El efecto del acceso abierto ).

How to Cite

1.
Sosa Rosado JM. New oral anticoagulants in thromboembolism prevention in nonvalvular atrial fibrillation. An Fac med [Internet]. 2013 Jun. 10 [cited 2024 Jul. 17];74(2):139-43. Available from: https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/2391